BIG updates

4 June marks National Cancer Survivors Day (in the US) – a moment to recognise

The latest edition of BIG Research in Focus highlights the POSITIVE trial. Clic here to discover it.

The HERA study: a new standard of care for HER2-positive breast cancer The HERA study,

At this year’s St. Gallen Breast Cancer Congress (SGBCC, 15-18 March 2023), Professor Giuseppe Viale

Results of the final analysis of the NeoALTTO study have been published in the European

The results of the combined SOFT-TEXT analysis after 13 years of follow-up are now published in the Journal of Clinical Oncology

On 7 December, a spotlight poster discussion on male breast cancer, including the work of

On Thursday 29 September, the Breast International Group had the honour of hosting its Honorary President, Her Royal Highness the Queen of the Belgians, around a round table session with over 40 influential people from the Belgian Business world.

The unmet needs of older patients with breast cancer The themed article of this edition

At the recent ASCO Annual Meeting 2022 Dr Etienne Brain received the B.J. Kennedy Geriatric

New Orleans, U.S.A. – Yesterday at the AACR Annual Meeting 2022 Dr Martine Piccart received the Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Award

In July 2021, we shared with you the first encouraging results from BIG’s OlympiA study. Updated results are even more encouraging.

On 17 March the first patient was randomised in the large AMEERA-6 trial, from a hospital in Chile. 

The positive results of the PYTHIA trial were published on 14 February in the European Journal of Cancer.